Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-PRKACG/PKA C gamma Antibody (R1S10)

Catalog #:   RHD53001 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IP, WB
Accession: P22612
Overview

Catalog No.

RHD53001

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IP: 1:20, WB: 1:500-1:1000

Target

cAMP-dependent protein kinase catalytic subunit gamma, PKA C-gamma, PRKACG

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P22612

Applications

IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1S10

Data Image
  • Western blot
    Western blot analysis of PRKACG in mouse testis, mouse lung lysates using PKA C gamma antibody.
  • Western blot
    Western blot analysis of PRKACG in MCF-7, C6, Hela lysates using PRKACG antibody.
References

Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma., PMID:40514070

A Promising Approach to Control Carbapenem-Resistant Acinetobacter baumannii: Investigating Immune Pathways Through rFilF Immunization., PMID:40513999

RACK1 promotes the development and function of alveolar macrophages through directly binding to and stabilizing PPARγ., PMID:40512793

Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma., PMID:40512454

TNFα signaling restores steady-state hematopoiesis in a TNFαKO mouse model of anemia of inflammation., PMID:40512402

IgA Antibodies to Bovine Serum Albumin in Adult Patients with Celiac Disease., PMID:40507813

FcRn inhibitors in immune thrombocytopenia: A comprehensive review of therapeutic advances and clinical outcomes., PMID:40505332

Identification of T-cell epitopes of the intracellular parasite Babesia bovis by immunopeptidomic analysis of BoLA-II presented peptides., PMID:40505327

Improved protection against H9N2 avian influenza virus challenge in chickens by the presence of LTB adjuvant on the 3M2e-NP nanoparticle vaccine delivered by sifA deficient Salmonella., PMID:40505226

A single dose of a CD137 antibody-drug conjugate protects nonhuman primate allogeneic HCT recipients against acute GVHD., PMID:40504994

Immunoblot-based activity assay for heme-containing histidine kinases., PMID:40501847

IL-18 inhibition enlarges lesions, necrotic cores and thickens fibrous caps in Jak2 V617F clonal hematopoiesis-driven atherosclerosis., PMID:40501724

Relaxation Processes in Freeze-Dried Monoclonal Antibody Formulations─The Role of Sucrose Concentration., PMID:40498081

Selected cytokine and chemokine concentrations in equine autologous conditioned serum are similar under defined and practically relevant storage conditions., PMID:40496923

T-cell responses induced by SARS-CoV-2 index-virus nanoparticle protein vaccine to the ancestral and omicron variants 6 months following primary vaccination., PMID:40494917

Immunoglobulin G4-related ophthalmic disease with orbital deep hemangioma: A case report., PMID:40494658

β-Amyloid as a new target to suppress tonic PTH hypersecretion in primary hyperparathyroidism., PMID:40492090

The real-world safety of Nivolumab: a pharmacovigilance analysis based on the FDA adverse event reporting system., PMID:40491923

A potent and broad CD4 binding site neutralizing antibody with strong ADCC activity from a Chinese HIV-1 elite neutralizer., PMID:40490455

Antigen-specific CD4+ T cells promote monocyte recruitment and differentiation into glycolytic lung macrophages to control Mycobacterium tuberculosis., PMID:40489538

Combining CD3/GD2 bispecific T cell engager with human Vγ9Vδ2 T cells facilitates neuroblastoma cell targeting and killing in vitro., PMID:40489497

Gamma-aminobutiric acid-B receptor antibody-related limbic encephalitis due to small cell lung carcinoma: Two case reports., PMID:40487548

Characteristics of polyclonal anti-interferon-gamma autoantibodies and novel diagnostic strategies: A prospective cohort study of new biomarkers., PMID:40485903

Informative event rate in study determination, study design, and interim analysis monitoring with non-proportional hazards., PMID:40485240

Acidic tumor microenvironment-modulated nanoparticle potentiates gastric cancer photoimmunotherapy., PMID:40484344

Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates., PMID:40482923

Grouper interleukin 15-like acts as a cytokine adjuvant in grouper iridovirus subunit vaccine., PMID:40482865

Serological analysis of gluten-related antibodies in idiopathic neuropathies and cerebellar ataxia., PMID:40481865

T cell memory alters pulmonary inflammatory responses to cecal ligation and puncture., PMID:40475466

Early de novo T cell expansion following SARS-CoV-2 infection predicts favourable clinical and virological outcomes., PMID:40472803

Protective Effect of Melissa officinalis (Lemon Balm) Extract on Cytokine Levels and Oxidative Stress in Ovalbumin Induced Lung Toxicity in Rats., PMID:40470741

Novel cancer stem cell-targeted retinoid ZSH-512 impedes colorectal cancer progress via KDM3A-mediated epigenetic reprogramming., PMID:40470327

Combined treatment with anti-PSMA antibody and human peripheral blood-derived NK cells for castration-resistant prostate cancer., PMID:40469300

Recall interferon-γ responses against Coccidioides are a surrogate marker for vaccine response in dogs., PMID:40466664

Impact of immune checkpoint TIGIT on the activation and function of natural killer cells in rheumatoid arthritis patients., PMID:40465407

Clinical Characteristics and Seizure Outcomes in Antibody-Positive Autoimmune Limbic Encephalitis., PMID:40463859

B and T lymphocyte attenuator (BTLA) and PD-1 pathway dual blockade promotes antitumor immune responses by reversing CD8+ T-cell exhaustion in non-small cell lung cancer., PMID:40463377

Humoral and cellular immune responses in cattle upon Clostridium chauvoei vaccination and challenge., PMID:40463373

Neutralizing Activity of Cervicovaginal Secretions against Herpes Simplex Virus is Mediated by Mucosal IgG and Viral Glycoprotein E and Adversely Impacted by Vaginal Dysbiosis., PMID:40463287

RNase 7 and Th cytokines synergistically increase the secretion of interleukin-6 from keratinocytes., PMID:40461723

Fc-optimized anti-CTLA-4 antibodies increase tumor-associated high endothelial venules and sensitize refractory tumors to PD-1 blockade., PMID:40460830

Optimization and validation of ELISAs for interferon-gamma determination in bison., PMID:40459381

Longitudinal analysis of cytokine dynamics in severe fever with thrombocytopenia syndrome patients - High-incidence regions of China (2010-2023)., PMID:40453472

Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccination., PMID:40452527

Fusion with CTB enhances the immunogenicity and protective efficacy of MIC2 subunit vaccine against Eimeria tenella., PMID:40449102

A ROS-Responsive Dual-Targeting Drug Nanocarrier Serving as a GSI Synergist and Ferroptosis Sensitizer for T-Cell Acute Lymphoblastic Leukemia., PMID:40448620

Neovascular pruning by IDO1 inhibitors can potentiate immunogenic cytotoxicity of ischemia-targeted agents to synergistically enhance anti-PD-1 responsiveness., PMID:40447318

Ovalbumin-specific regulatory T cells differentiated from the naïve phenotype (CD44loCD62Lhi) in mesenteric lymph nodes stably suppress enteropathy even in severe food-allergic mice., PMID:40446078

An activating Stat1 mutant disrupts normal STAT4 innate lymphocyte programs during viral infection., PMID:40446018

Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency., PMID:40445758

Datasheet
$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-PRKACG/PKA C gamma Antibody (R1S10) [RHD53001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only